Volume 6 Supplement 3

AIDS Vaccine 2009

Meeting abstracts

Edited by Anna Laura Ross

AIDS Vaccine 2009. Go to conference site.

Paris, France19-22 October 2009

Concatenated PDF 6S3

Content type: Oral presentation

OA011-05. TLR-mediated pDC responses to HIV-1 ligands

Authors: J Chang, S Kulkarni, A Meier, RJ Lindsay, S Bazner, JD Lifson, RJ Bosch, M Carrington and M Altfeld

Citation: Retrovirology 2009 6(Suppl 3):O11

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine

Authors: J Liu, N Ngai, GW Stone, F Yue and MA Ostrowski

Citation: Retrovirology 2009 6(Suppl 3):P11

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission

Authors: JR Lingappa, JP Hughes, D Donnel, JM Baeten, JI Mullins, MS Campbell, GE Gray, M Essex, C Farquhar, H Rees, A Wald, L Corey and C Celum

Citation: Retrovirology 2009 6(Suppl 3):O12

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-07. High concentrations of interleukin-15 and low concentrations of CCL5 in breast milk are associated with protection against postnatal HIV transmission

Authors: J Walter, MK Ghosh, L Kuhn, K Semrau, M Sinkala, C Kankasa, DM Thea and GM Aldrovandi

Citation: Retrovirology 2009 6(Suppl 3):P12

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

Authors: B Jacobs, K Kibler, S Wong, T Huynh, S Holechek, K Denzler, W Arndt, M Parrington, J Tartaglia and G Pantaleo

Citation: Retrovirology 2009 6(Suppl 3):O13

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant

Authors: J Sun, Y Liu, D Li, J Hou, Z Xu, W Fan, J Fu, Y Liu and Y Shao

Citation: Retrovirology 2009 6(Suppl 3):P13

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV

Authors: F Tangy, M Février, M Guerbois, C Combredet, V Najburg, C Ruffié, A Morris, O Schwartz and R Legrand

Citation: Retrovirology 2009 6(Suppl 3):O14

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-09. Dissecting the interference of endotoxins with HIV infection of primary CD4 T cell

Authors: A Krarup, P Rusert and A Trkola

Citation: Retrovirology 2009 6(Suppl 3):P14

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env

Authors: AK Wheatley, MR Alexander, JG Toe, RJ Center and DF Purcell

Citation: Retrovirology 2009 6(Suppl 3):O15

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1

Authors: SA Kessans, J Frater, N Matoba and T Mor

Citation: Retrovirology 2009 6(Suppl 3):P15

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies

Authors: X Shen, M Dennison, F Gao, DC Montefiori, L Verkoczy, B Haynes, M Alam and G Tomaras

Citation: Retrovirology 2009 6(Suppl 3):O16

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-11. Correlate of local adjuvanticity and inflammation for experimental vaginal adjuvants in mice

Authors: M Lindqvist, N Navabi, M Jansson, Å Sjöling, C Örndal and AM Harandi

Citation: Retrovirology 2009 6(Suppl 3):P16

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein

Authors: IC Lorenz, HT Nguyen, SK Phogat, SM Kaminsky, TJ Zamb and CL Parks

Citation: Retrovirology 2009 6(Suppl 3):O17

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes

Authors: DS Rosa, SP Ribeiro, EC Mairena, J Kalil and E Cunha-Neto

Citation: Retrovirology 2009 6(Suppl 3):P17

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro

Authors: J Cummings, V Arnold, K Yarbrough, C Didier, Y Levy, F Barré-Sinoussi and D Scott-Algara

Citation: Retrovirology 2009 6(Suppl 3):O18

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy

Authors: JK Craigo, CJ Issel and RC Montelaro

Citation: Retrovirology 2009 6(Suppl 3):P18

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA031-01. HIV-1 infection is characterized by early loss of CD161+ Th17 cells and gradual decline in regulatory T cells

Authors: A Prendergast, JG Prado, Y Kang, F Chen, LA Riddell, G Luzzi, P Goulder and P Klenerman

Citation: Retrovirology 2009 6(Suppl 3):O19

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination

Authors: LE Gonzalez, N Strbo and ER Podack

Citation: Retrovirology 2009 6(Suppl 3):P19

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Oral presentation

OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway

Authors: M Nikolova, M Carriere, J Lelievre, M Muhtarova, A Bensussan and Y Lévy

Citation: Retrovirology 2009 6(Suppl 3):O20

Published on: 22 October 2009
- View Full Text
- View PDF
Content type: Poster presentation

P03-03. Protection against SIV by anti HLA class II specific antibody in the macaque model

Authors: MJ Robinson, R Quartey-Papafio, N Almond and M Page

Citation: Retrovirology 2009 6(Suppl 3):P20

Published on: 22 October 2009
- View Full Text
- View PDF

Retrovirology

AIDS Vaccine 2009

Meeting abstracts

OA011-05. TLR-mediated pDC responses to HIV-1 ligands

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine

OA01-06 LB. HIV-1 plasma RNA and risk of HIV-1 transmission

P02-07. High concentrations of interleukin-15 and low concentrations of CCL5 in breast milk are associated with protection against postnatal HIV transmission

OA021-01. Construction and characterization of replication competent attenuated NYVAC-based vectors as potential HIV vaccines

P02-08. Enhancement of HIV-1 DNA vaccine immunogenicity by BCG-PSN, a novel adjuvant

OA021-02. Replicating measles-SHIV vaccine induces long term preservation of central memory CD4 cells in the gut of vaccinated macaques challenged with SHIV

P02-09. Dissecting the interference of endotoxins with HIV infection of primary CD4 T cell

OA021-03. Design and development of DNA vaccines for the co-expression of micro-RNA and HIV-1 Env

P02-10. Plant expression of chimeric Gag/gp41 virus-like particles as a mucosally-targeted subunit vaccine against HIV-1

OA021-04. HIV-1 gp41 envelope MPER mutation altered epitope conformation in lipid and increased sensitivity to 2F5 and 4E10 neutralizing antibodies

P02-11. Correlate of local adjuvanticity and inflammation for experimental vaginal adjuvants in mice

OA021-05. Insertion of the HIV-1 gp41 epitopes 2F5 and 4E10 into the membrane-proximal region of the vesicular stomatitis virus glycoprotein

P02-12. Bupivacaine, a local anaesthetic, enhances immunogenicity of a multiepitopic DNA vaccine containing HIV promiscuous CD4 T cell epitopes

OA02-06 LB. Recombinant modified Vaccinia virus ankara expressing HIV-1 genes activates NK subset capable of controlling HIN infection in vitro

P03-01. The relationship of envelope evolution to lentiviral persistence and vaccine efficacy

OA031-01. HIV-1 infection is characterized by early loss of CD161+ Th17 cells and gradual decline in regulatory T cells

P03-02. SCID-hu mice generate HIV specific human immune responses after gp96 vaccination

OA031-02. Regulatory T cells inhibit CD8 T cell proliferation in HIV-1 infection through CD39/adenosine pathway

P03-03. Protection against SIV by anti HLA class II specific antibody in the macaque model

Follow

2017 Journal Metrics

Retrovirology

Contact us